Use of an in vivo FTA assay to assess the magnitude, functional avidity and epitope variant cross-reactivity of T cell responses following HIV-1 recombinant poxvirus vaccination
about
The Influence of Immunization Route, Tissue Microenvironment, and Cytokine Cell Milieu on HIV-Specific CD8+ T Cells Measured Using Fluidigm Dynamic Arrays.Immune Signature of Enhanced Functional Avidity CD8+ T Cells in vivo Induced by Vaccinia Vectored Vaccine.Recombinant fowlpox virus vector-based vaccines: expression kinetics, dissemination and safety profile following intranasal delivery.Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice.
P2860
Use of an in vivo FTA assay to assess the magnitude, functional avidity and epitope variant cross-reactivity of T cell responses following HIV-1 recombinant poxvirus vaccination
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Use of an in vivo FTA assay to ...... combinant poxvirus vaccination
@ast
Use of an in vivo FTA assay to ...... combinant poxvirus vaccination
@en
Use of an in vivo FTA assay to ...... combinant poxvirus vaccination
@nl
type
label
Use of an in vivo FTA assay to ...... combinant poxvirus vaccination
@ast
Use of an in vivo FTA assay to ...... combinant poxvirus vaccination
@en
Use of an in vivo FTA assay to ...... combinant poxvirus vaccination
@nl
prefLabel
Use of an in vivo FTA assay to ...... combinant poxvirus vaccination
@ast
Use of an in vivo FTA assay to ...... combinant poxvirus vaccination
@en
Use of an in vivo FTA assay to ...... combinant poxvirus vaccination
@nl
P2093
P2860
P50
P1433
P1476
Use of an in vivo FTA assay to ...... combinant poxvirus vaccination
@en
P2093
Benjamin J C Quah
Charani Ranasinghe
Christopher R Parish
P2860
P304
P356
10.1371/JOURNAL.PONE.0105366
P407
P577
2014-01-01T00:00:00Z